Background: Early detection of pancreatic ductal adenocarcinoma (PDAC) remains elusive. Precursor lesions of PDAC, specifically, intraductal papillary mucinous neoplasms (IPMNs) represent a bona fide pathway to invasive neoplasia, although the molecular correlates of progression remain to be fully elucidated. Single cell transcriptomics provides a unique avenue for dissecting both the epithelial and microenvironmental heterogeneity that accompany multistep progression from noninvasive IPMNs to PDAC.
Introduction
Pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancerrelated deaths in the United States, and most patients present with unresectable disease due to the lack of effective early detection strategies [1] . This reiterates the critical need for understanding the pathogenesis of early neoplasia with the goal of developing biomarkers and molecular targets for cancer interception. The most common cystic neoplasm that is a bona fide precursor to PDAC is Intraductal Papillary Mucinous Neoplasms (IPMNs), which comprise roughly 40-50% of resected lesions that are initially diagnosed as asymptomatic pancreatic cysts [2] . While most IPMNs harbor low-grade dysplasia (LGD), it is imperative to distinguish IPMNs that have progressed to highgrade dysplasia (HGD), or harbor an outright invasive component (PDAC). To guide clinicians with identifying IPMNs harboring HGD or PDAC, several radiological "high risk"
or "worrisome features" (so-called Sendai and Fukuoka criteria) have been proposed [3] .
Although the rate of overdiagnosis and over-treatment have been significantly reduced, these criteria still lack optimal sensitivity and specificity [4] . While patients with noninvasive IPMNs have an excellent prognosis upon surgical resection, once an IPMN develops an invasive component, the probability of long-term survival drops significantly [5] . Although we have now elucidated the signature driver mutations (KRAS and GNAS) that distinguish IPMNs from other pancreatic cysts, these do not reliably distinguish between indolent versus aggressive IPMNs [6, 7] . In fact, the overall state of knowledge remains rudimentary, especially with regards to molecular metrics that can identify 'aggressive' precancerous lesions that are likely to progress to carcinoma and require intervention from those that are 'indolent' and will naturally regress or remain stable.
Thus, much remains to be elucidated in terms of biomarkers of IPMN progression and the underlying molecular features of dysplastic cells that predicate to invasive neoplasia.
The application of single cell DNA and RNA sequencing to cancers has provided unprecedented insights into tumor and microenvironmental heterogeneity present in established cancers.
However, the extrapolation of these technologies to the compendium of precursor lesions has been scarce. In the specific context of the pancreas, prior studies have established the transcriptional profiles of normal cell types, such as islet cells, using single cell approaches [8] [9] [10] . In this study, we perform the first reported single cell transcriptomic profiling of cystic precursor lesions of PDAC spanning histological grades of dysplastic epithelium. Specifically, we demonstrate our ability to generate transcriptomic libraries from >5400 single cells from surgically resected pancreatic tissues, including two IPMN with LGD, two IPMNs with HGD, and two PDAC lesions utilizing a droplet-based single-cell RNA-seq methodology [11] . Our results demonstrate that epithelial and stromal heterogeneity is evident even within precursor lesions during multistep carcinogenesis, and reflect the progressive co-option of the microenvironment towards a tumor-promoting milieu.
Results

Concordance of single cell RNA sequencing to bulk cell lines
Prior to tissue profiling, we investigated the concordance of bulk and single cell RNA Figure 1A) . We also verified the concordance of gene counts across two independent replicates of single cell library preparation from the same cell line sample. This revealed a high correlation in gene expression levels (r s > 0.9) with almost identical levels of gene coverage (14,994 and 14,488) (Supplementary Figure 1B) .
Preneoplastic epithelium of IPMNs demonstrates both unique and shared transcriptomic signatures with PDAC
We subsequently applied droplet-based single cell RNA sequencing to study the diverse transcriptional profiles that exist within surgically resected preneoplastic (IPMNs) and Figure 1D) to use for unsupervised clustering using t-distribution stochastic neighbor embedding (t-SNE) [12] which was implemented using the SEURAT package ( Figure 1A ) [11] . This analysis identified ten We first identified the neoplastic single cell "clusters" through previously defined signature transcripts for pancreatic epithelial lesions, including KRT19 and MUC1, which were present among all samples types (IPMNs and PDAC) irrespective of grade if dysplasia or invasion [13, 14] (Figure 2A) . We subsequently sought to correlate the histological grading of the designated "clusters" with known biomarkers of dysplastic progression to cancer. This revealed high expression of transcripts like CEACAM6 within subpopulations of HGD-IPMN and PDAC samples, which confirmed previously published data on this marker in bulk RNA analysis and immunohistochemistry of intact tissues [15, 16] . Conversely, we observed high expression of MUC5AC, which encodes for an apomucin mostly seen in LGD and downregulated during histological progression, within the LGD-IPMNs compared to the other sample types [13] .
In an effort to identify "cluster-defining" signatures, we profiled the top 25 differentially expressed genes within each of the ten distinct single cell "cluster" (Figure 2B , Supplementary Table 2 ). Annotation of the resulting transcripts revealed aberrant expression of multiple cancer-related genes even within the LGD-IPMN cells (designated as "clusters" LG.Ep1, 2, and 3 ( Figure 1B) . These include overexpression of transcripts such as TFF3 and REG4 that have been previously described as upregulated during cancer progression [17, 18] . On the contrary, the LGD-IPMN clusters demonstrated persistent expression of putative tumor suppressor genes (TSGs) such as RAP1GAP
that have been shown to suppress tumor invasion and metastases across various cancers (including RAS mutant neoplasms) [19] , while HGD-IPMNs (HG.Ep) revealed downregulation of the aforementioned TSGs, concomitant with higher expression of oncogenic transcripts previously associated with progression to PDAC such as S100P
and S100A10, amongst others [20] [21] [22] .
We then investigated whether biological differences could be observed through gene ontology and pathway analysis (IPA: Ingenuity Pathways Analysis) of differentially expressed genes between neoplastic epithelial clusters ( Figure 1B) . Several aberrant canonical pathways were identified during the transition from LGD to HGD IPMN that are related to previously published core signaling pathways in PDAC, including integrin signaling, signaling by small GTPases, Wnt/B-catenin signaling, axonal guidance signaling, apoptosis, and G1/S phase regulation ( Supplementary Table 3 ) [23, 24] .
When comparing the PDAC and LGD lesions, the differential expression between all of these pathways was maintained, with the additional deregulation of DNA damage response, TGF-B signaling, and SAPK/JNK signaling. Other aberrant canonical pathways identified during transition from LGD to HGD and PDAC lesions include metabolism related pathways such as oxidative phosphorylation and mitochondrial dysfunction, as well as mTOR signaling ( Supplementary Table 4 ).
It is important to note that even "adenocarcinoma"-designated clusters contained cells originating from LGD-IPMNs with associated expression of PDAC core signaling pathways and deregulation of tumor suppressor genes (Figure 2C) (Figure 2D) , a not surprising finding suggesting an increase in intra-tumoral epithelial heterogeneity during the progression from IPMNs to PDAC [25] . Inter-lesion correlation was better observed in cells derived from stromal components including myeloid and lymphocytic populations, whereby a significant number of populations showed similarities across tissue types (Figure 1A-C) . This suggests the presence of common cancer associated immune components among lesion types. On the other hand, even though these stromal components tended to cluster with one another ( Figure 1B) , correlation heat maps suggested the presence of multiple unique subtypes within the stroma and non-random variations during histological progression to cancer (Supplementary Figure 4 , and results below).
Virtual microdissection of stromal and immune heterogeneity during IPMN progression
In an effort to better identify unique subpopulations of stromal components across lesion types, we opted to perform single cell digital microdissection of only stromal cells and exclude epithelial components. This resulted in the identification of seven unique clusters with varying degrees of enrichment across lesions types (Figures 3a,b) . (ITGAM) , S100A9, CCL3, and APOE, which has been previously described to be prevalent during cancer progression [29] . Among myeloid derived populations, we also observed cDC2 type dendritic cells, characterized by expression of CD1C, THBD, and FCER1A [30] . These cells have been shown to have T-cell stimulatory potential and are critical mediators of cross presentation of tumor antigens mediated through the high-affinity IgE receptor FcεRI (FCER1A) [31] . This proinflammatory subpopulation appears in greater proportions amongst LGD and HGD-IPMNs, suggesting a more prevalent predication for anti-tumor immune response within pre-neoplastic lesions.
Heterogeneous fibroblast populations across histological subtypes were also identified potentially representing distinct stromal functions during tumorigenesis. For example, the fibroblast subtype known as "inflammatory" CAF (iCAF) is characterized by expression of VIM, FAP, COL3A1, DES, IL6, and CXCL12 and reduced expression of a-SMA (ACTA2) [32, 33] . This subpopulation has been shown to be involved in immunosuppression, growth factor secretion, and promotion of pro-tumorigenic mechanisms facilitating invasion and metastasis [32] , which might correlate with its exclusive representation in PDAC derived clusters, representing 10.5% (58/544) of single stromal cells profiled, and absence within non-invasive IPMNs. A separate compartment of CAFs, described as myofibroblasts ("myCAFs"), with increased alpha-SMA expression and reduced expression of CXCL12 and DES, was also identified.
These myCAFs have been implicated in distinct functions from iCAFs, including secretion of autocrine stromal and endothelial growth factors [32] . This population is rare in LGD-IPMNs, but is highly represented in HGD-IPMNs suggesting that activation of fibroblasts to the myCAF phenotype tends to occur even within non-invasive dysplastic lesions (Figure 4 ).
Discussion
Histologically well-established precancerous lesions precede the onset of PDAC by years, if not decades. Although much has been described in regards to the genomic alterations in these precursor lesions, the overall state of knowledge remains rudimentary, especially with regards to molecular metrics that can identify 'aggressive' precancerous lesions that require intervention from those that are 'indolent' and will naturally regress or remain stable. In the current study, we describe an approach at profiling the molecular events that occur during pancreatic carcinogenesis in the context of cystic precursors (IPMNs) with the goal of understanding the heterogeneity of epithelial and stromal components that might delineate lesions with an aggressive potential. We do this through high-resolution single cell RNA sequencing of LGD-IPMN, HGD-IPMN, and PDACs, which allows us to specifically profile aberrant pathways across multiple cell types. Interestingly, progression from LGD and HGD lesions to invasive PDAC revealed shifts in distinct cell populations encompassing both epithelial and stromal/immune compartments.
Among epithelial populations, we detected expression of transcripts of gastric lineage that have been previously described during IPMN progression and have been correlated with better prognosis, such as MUC5AC, as differentially overexpressed in our LGD lesions [34] . Although oncogenic transcripts are also expressed at the LGD stage, there appears to be retained expression of tumor suppressor related pathways which may help counteract further dysplastic progression of these lesions. Within HGD lesions, differential expression of these tumor suppressor pathways are no longer detected and we begin to find previously described classical core signaling pathways in PDAC [24, 35] .
As a stroma-rich cancer, multiple studies have shown how the diverse tumor microenvironment (TME) plays a crucial role in the development, progression, and immune evasion that exemplifies the biology of PDAC [36, 37] . As previously shown by Moffit et al., "virtual microdissection" of stromal genes revealed an "activated" subpopulation of stroma characterized by overexpression of inflammatory pathways [38] .
Although these findings are further validated within our own study, Moffit et al., were not able to distinguish specific contributions of immune and myofibroblast components to this signature. By dissecting specific cell-types at the single cell level, we further delineate this signature to describe the dichotomy of "myCAF" versus "iCAF" fibroblast populations during multistep progression, with the former cells observed (albeit rarely) even in LGD-IPMNs and the latter cells only identified in PDAC samples. Within our analysis, besides expression of many typical CAF markers (FAP, THY1, and DES), the iCAF cells also show a unique expression pattern of the C-X-C motif chemokine ligand 12 (CXCL12) [39] . This chemokine and its corresponding receptor (CXCR4) are believed to play a crucial role in many solid cancers, and are associated with metastatic spread in breast cancer, lung cancer and melanoma [40] [41] [42] [43] . Accumulating evidence also points to a role in PDAC progression, with higher expression of CXCL12 correlating with metastasis, likely by facilitating immune evasion, and increased levels of matrix metalloproteinases leading to cellular invasion [44] [45] [46] [47] . Within our own study, we find similar trends in the presence of other cellular populations that parallel the emergence of CXCL12-expressing iCAFs, such as a decrease in cytotoxic T cell and increase in myeloid suppressive proportions, creating the notorious immune suppressive TME well described in PDAC.
Myeloid derived subpopulations also tend to evolve during tumor progression.
Comprised of multiple clusters expressing CD11b, ITGB2, CD13, CD18, and S100A9, a populations within LGD and HGD IPMN microenvironment suggests a pro-inflammatory phase that is present during the non-invasive precursor states. This is particularly true in
LGD IPMNs where a higher proportion of cytotoxic T cells exist in comparison to other lesion types that may be supported by cDC2 cells through cross presentation of tumor antigens and T-cell stimulation. Additionally, the presence of these dendritic cells in IPMNs may also provide opportunities for cancer "immune interception", since dendritic cell targeted vaccines have previously shown effectiveness in the context of an myeloid immunosuppressive environment through reduction of PMN-MDSCs [52] .
In conclusion, we describe how the TME may evolve during the multistep progression of IPMNs to PDAC, whereby the non-invasive precursor lesions begin to experience a loss of cytotoxic T-cells during dysplastic progression and begin to assimilate immune components such as PMN-MDSCs, with immune suppressive properties. Additionally, we demonstrate this permissive microenvironment is correlated with appearance of tumor-promoting iCAF stromal cell populations that facilitate immune evasion. Notably, single cell analysis of IPMNs reveals, for the first time, that even in otherwise histologically innocuous LGD-IPMNs, we find minor populations of cells that transcriptionally phenocopy HGD and PDAC (~9% and ~1% of LGD-IPMN cells, respectively). It is possible that future single cell analyses on a larger series of LGD-IPMNs might establish a "threshold" which portends aggressive natural history even in the absence of radiologically detectable worrisome features. Although it is important to stress the limited generalizations that can be made from such a small subset of lesions, the ability to detect these gene expression patterns among single cells provides a primer for uncovering how heterogeneous cell types contribute to tumor carcinogenesis.
Leveraging this strategy may thus facilitate elucidation of molecular biomarkers for disease stratification.
Materials and methods
Preparation of fresh tissue material from surgically resected IPMNs or PDAC
A total of six patients were recruited at MD Anderson Cancer Center (MDACC) and For warm digestion of PDAC tissues, we followed the identical procedure above as the IPMNs, followed by a second digestion period using sterile-filtered Accutase® solution, and placed on a shaker at 37 °C, 225 RPM for 30min, with gentle pipetting every 10 minutes.
ddSEQ Surecell Library Preparation
Single cell transcriptomic amplification and library prep was performed using the 
Single cell clustering and transcriptomic analyses
Resulting FastQ files were run through the Single cell RNA-seq app on BaseSpace.
Briefly, reads were aligned against a reference genome using Spliced Transcripts Alignment to a Reference (STAR), followed by barcode tagging and BAM indexing [53] .
Count files are generated using gene UMI counter and with cells passing quality filter based on cells above background and passing knee filter. Gene ontology and KEGG pathway analyses are performed using annotation functions of the R limma package.
To perform the T-SNE clustering and additional downstream analyses, the UMI count files were compiled into sparse matrices and subsequently filtered based on the criteria that each cell must express a minimum of 300 genes and be composed of less than 10% mitochondrial genes. The data was then log normalized, followed by the identification of variable genes. The number of UMIs and the percentage of mitochondrial genes was regressed out, and the resulting data was scaled and centered. The sparse matrix is analyzed by PCA and then run through a jackstraw algorithm to estimate statistical significance between the genes and principal components. After using this analysis to determine the number of dimensions to use, the result was clustered in a shared nearest neighbor algorithm and T-SNE before plotting. These annotated matrices were also used to find differentially expressed genes between subpopulations. The resulting T-SNE plots were colored according to specific features to visually present expression of genes in various clusters. Functions for analysis provided in the Seurat package [11] .
The correlation matrices were created based on the filtered list of cells used in the T-SNE. Matrices were formed through the function 'cor' from the stats package. The
Pearson correlation coefficients were then plotted in ComplexHeatmap [54] . Cells are ordered through hierarchical clustering. Both T-SNE and correlation heatmaps were created in R v3.4.2 
Figure Legends
